/
IDXG
$1.68+$0.03 (+1.82%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.75 – $2.40
56% from low
Exchange
OTC Link
CS
Borrow rate
1.00%
Moderate
Price (6 mo)
Loading chart…
Change$-5.79
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.9M | $24.1M | $32.4M | $41.3M | $31.8M | $40.2M | $46.9M | $38.7M |
| Cost of revenue | $10.2M | $15.9M | $21.7M | $23.4M | $13.6M | $16.3M | $17.0M | $14.6M |
| Gross profit | $11.7M | $8.2M | $10.7M | $17.9M | $18.2M | $23.9M | $29.9M | $24.1M |
| Gross margin | 53.4% | 34.0% | 33.1% | 43.4% | 57.3% | 59.4% | 63.8% | 62.3% |
| R&D | $2.1M | $2.8M | $2.8M | $1.9M | $703.0K | $636.0K | $676.0K | $642.0K |
| Operating income | −$12.1M | −$23.9M | −$26.6M | −$11.7M | −$3.8M | $2.8M | $8.1M | $4.1M |
| EBITDA | −$8.6M | −$21.7M | −$20.1M | −$1.3M | −$2.3M | $3.8M | $8.4M | $4.8M |
| Net income | −$12.2M | −$26.6M | −$26.2M | −$14.7M | −$5.9M | $802.0K | $6.7M | $24.6M |
| Net margin | -55.7% | -110.6% | -80.9% | -35.7% | -18.4% | 2.0% | 14.3% | 63.5% |
| EPS (diluted) | -4.33 | -7.11 | -6.50 | -3.57 | -1.38 | 0.18 | 0.40 | 0.89 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$1.28
Price
$1.68
Implied downside
-24%
Peer comparison
INTERPACE BIOSCIENCES INC
INTERPACE BIOSCIENCES INC
Held by traders on TradeandTell
No one on the platform currently holds IDXG.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in IDXG as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2020-01-15 | 1-for-10reverse |
| 2016-12-29 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded IDXG yet.
